Tone Atsuhito, Shikata Kenichi, Matsuda Mitsuhiro, Usui Hitomi, Okada Shinichi, Ogawa Daisuke, Wada Jun, Makino Hirofumi
Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.
Diabetes Res Clin Pract. 2005 Sep;69(3):237-42. doi: 10.1016/j.diabres.2005.02.009. Epub 2005 Mar 23.
Although persistent proteinuria is characteristic of diabetic nephropathy (DN), it is important to differentiate non-diabetic renal diseases (NDRD) in diabetic patients with proteinuria. In order to re-evaluate the indications for renal biopsy in the diabetic patients, we retrospectively analyzed the relationship between clinical features and histological diagnosis in 97 Japanese patients with type 2 diabetes manifesting overt proteinuria. Renal biopsy was performed because they were clinically suspected to have NDRD. Patients were divided into three groups according to the histological diagnosis: (1) the DN group (n=35) had only diabetic lesions, (2) the complicated group (n=16) had histological changes of NDRD superimposed on DN and (3) the non-DN group (n=46) had NDRD without diabetic lesions. We evaluated the specificity and sensitivity of four clinical parameters (duration of diabetes, presence or absence of diabetic retinopathy, microscopic hematuria and granular casts as urinary sediments) for the prediction of NDRD. Short duration of diabetes (<5 years) showed high sensitivity (75%) and specificity (70%). Diabetic retinopathy showed the highest sensitivity (87%) and specificity (93%). The sensitivity and specificity of microscopic hematuria (56 and 58%) and granular casts (68 and 47%) were lower. Our study confirmed that the absence of retinopathy and short duration of diabetes are useful clinical indications for renal biopsy in diabetic patients with overt proteinuria.
尽管持续性蛋白尿是糖尿病肾病(DN)的特征,但在有蛋白尿的糖尿病患者中鉴别非糖尿病性肾脏疾病(NDRD)很重要。为了重新评估糖尿病患者肾活检的指征,我们回顾性分析了97例表现为显性蛋白尿的日本2型糖尿病患者的临床特征与组织学诊断之间的关系。进行肾活检是因为临床怀疑他们患有NDRD。根据组织学诊断将患者分为三组:(1)DN组(n = 35)仅有糖尿病病变;(2)合并组(n = 16)有叠加在DN上的NDRD组织学改变;(3)非DN组(n = 46)有NDRD但无糖尿病病变。我们评估了四个临床参数(糖尿病病程、糖尿病视网膜病变的有无、镜下血尿以及尿沉渣中的颗粒管型)对NDRD预测的特异性和敏感性。糖尿病病程短(<5年)显示出高敏感性(75%)和特异性(70%)。糖尿病视网膜病变显示出最高的敏感性(87%)和特异性(93%)。镜下血尿(56%和58%)和颗粒管型(68%和47%)的敏感性和特异性较低。我们的研究证实,无视网膜病变和糖尿病病程短是显性蛋白尿糖尿病患者肾活检的有用临床指征。